Purpose: This work describes a unique clinical feature in Coats disease. Methods: A retrospective series of 2 cases is reported. Results: Two pediatric patients receiving treatment for Coats disease were included. In both cases, vision worsened secondary to paradoxically increased exudation and macular star formation following standard treatment with intravitreal bevacizumab, sub-Tenon triamcinolone acetonide, and laser photocoagulation. After serial treatments under general anesthesia, the exudates in both cases consolidated. Conclusions: A paradoxical exudative retinopathy can occur in some patients when initiating standard treatment of Coats disease. Longitudinal follow-up with continued intravitreal antivascular endothelial growth factor agents, laser photocoagulation, and corticosteroids might help control persistent exudation in these cases.
MorrisBFootBMulvihillA.A population-based study of Coats disease in the United Kingdom I: epidemiology and clinical features at diagnosis. Eye (Lond). 2010;24(12):1797-1801. doi:10.1038/eye.2010.126
2.
SiglerEJRandolphJCCalzadaJIWilsonMWHaikBG.Current management of Coats disease. Surv Ophthalmol. 2014;59(1):30-46. doi:10.1016/j.survophthal.2013.03.007
3.
GilmourDF.Familial exudative vitreoretinopathy and related retinopathies. Eye (Lond). 2015;29(1):1-14. doi:10.1038/eye.2014.70
4.
KusakaS.Surgical management of Coats disease. Asia Pac J Ophthalmol (Phila). 2018;7(3):156-159. doi:10.22608/APO.201867
PatelNBerrocalAMMurrayTGVillegasVM.Advanced Coats’ disease treated with intravitreal brolucizumab combined with laser photocoagulation. Am J Ophthalmol Case Rep. 2020;19:100815. doi:10.1016/j.ajoc.2020.100815
7.
Jeng-MillerKYonekawaYMukaiS. Pediatric retinal vascular diseases. In: AlbertDMillerJAzarDYoungLH, eds. Albert and Jakobiec’s Principles and Practice of Ophthalmology. Springer; 2021. doi:10.1007/978-3-319-90495-5_31-1
8.
OngSBuckleyEGMcCuenBWII, et al. Comparison of visual outcomes in Coats’ disease: a 20-year experience. Ophthalmology. 2017;124(9):1368-1376. doi:10.1016/j.ophtha.2017.03.051
9.
ChiuHWanMJKertesPJMuniRHLamWC.Visual outcomes after treatment in pediatric patients with Coats’ disease. Can J Ophthalmol. 2019;54(6):647-652. doi:10.1016/j.jcjo.2019.02.004
10.
AyataAUnalMErşanliDTatlipinarS.Fundus autofluorescence imaging of macular star. Acta Ophthalmol. 2009;87(6):690-691. doi:10.1111/j.1755-3768.2008.01299.x
11.
Galvez-RuizA.Macular star formation in diabetic patients with non-arteritic anterior ischemic optic neuropathy (NA-AION). Saudi J Ophthalmol. 2015;29(1):71-75. doi:10.1016/j.sjopt.2014.09.002
12.
MoshfeghiDMSilvaRABerrocalAM.Exudative retinal detachment following photocoagulation in older premature infants for retinopathy of prematurity: description and management. Retina. 2014;34(1):83-86. doi:10.1097/IAE.0b013e3182993d5f
13.
KumarPKumarV.Vitrectomy for epiretinal membrane in adult-onset Coats’ disease. Indian J Ophthalmol. 2017;65(10):1046-1048. doi:10.4103/ijo.IJO_322_17
14.
KanEYilmazTAydemirOGülerMKurtJ.Coats-like retinitis pigmentosa: reports of three cases. Clin Ophthalmol. 2007;1(2):193-198.
15.
RamanRNittalaMGGellaLPalSSSharmaT.Retinal sensitivity over hard exudates in diabetic retinopathy. J Ophthalmic Vis Res. 2015;10(2):160-164. doi:10.4103/2008-322X.163771
16.
OngSSCummingsTJVajzovicLMruthyunjayaPTothCA.Comparison of optical coherence tomography with fundus photographs, fluorescein angiography, and histopathologic analysis in assessing Coats disease. JAMA Ophthalmol. 2019;137(2):176-183. doi:10.1001/jamaophthalmol.2018.5654
17.
AshkenazyNAconDKalavarMBerrocalAM.Optical coherence tomography angiography and multimodal imaging in the management of Coats’ disease. Am J Ophthalmol Case Rep. 2021;23:101177. doi:10.1016/j.ajoc.2021.101177
